Publications

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

 98
Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Tags:

Previous Article

Increased cholesterol synthesis drives neurotoxicity in multiple sclerosis

Next Article

Animal model for antitumor immunity in lung cancer

Related Posts

Hippo signalling in cellular and tissue-level metabolism across health and disease

Hippo signalling in cellular and tissue-level metabolis...

 38

A genome-first study of sex chromosome aneuploidies provides evidence of Y chromosome dosage effects on autism risk

A genome-first study of sex chromosome aneuploidies pro...

 87

Fixed and flexible perceptual rhythms

Fixed and flexible perceptual rhythms

 94